Hepatitis B Infection Clinical Trial
Official title:
Clinical Follow-up Study on Hepatitis B Virus Infection After Liver Transplantation in Children
China is a highly prevalent area of hepatitis B virus（HBV） infection, with at least 75 million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is associated with chronic hepatitis B virus infection. Liver transplantation is currently the preferred method for end-stage liver disease such as biliary atresia and cirrhosis in children. In recent years, children's liver transplantation has developed rapidly and the number of developments has increased significantly. If there is chronic hepatitis B virus infection in the donor liver, it may cause HBV transmission, or the patient may have a low-load occult hepatitis B virus infection, and after immunosuppressive treatment, it may lead to hepatitis B virus infection after surgery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04704024 -
Reducing Vertical Transmission of Hepatitis B in Africa
|
Phase 3 | |
| Active, not recruiting |
NCT02143401 -
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
|
Phase 1 | |
| Completed |
NCT00371150 -
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
|
Phase 4 | |
| Active, not recruiting |
NCT03519113 -
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
|
Phase 2/Phase 3 | |
| Completed |
NCT01788371 -
Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
|
Phase 4 | |
| Recruiting |
NCT06368479 -
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
|
N/A | |
| Completed |
NCT01488526 -
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
|
Phase 4 | |
| Terminated |
NCT02826018 -
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection
|
Phase 1 | |
| Completed |
NCT01970254 -
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
||
| Completed |
NCT00489099 -
A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)
|
Phase 3 | |
| Recruiting |
NCT03476083 -
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
|
Phase 4 | |
| Completed |
NCT03627507 -
Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.
|
Phase 2/Phase 3 | |
| Completed |
NCT02443233 -
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
|
N/A | |
| Completed |
NCT00841477 -
An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
|
Phase 3 | |
| Terminated |
NCT03887702 -
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
|
Phase 3 | |
| Completed |
NCT02304315 -
A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients
|
Phase 2 | |
| Active, not recruiting |
NCT05117541 -
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
|
||
| Not yet recruiting |
NCT06368466 -
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites
|
N/A |